Loading insider details...
Beta
Latest Form 4 (Apr 2, 2024): Grant/Award of 21,250 PTIX shares, $37.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 2, 2024 | Protagenic Therapeutics, Inc.\new (PTIX) | Grant/Award | 21,250 | $37.0K |
| Jun 13, 2022 | MIMEDX GROUP, INC. (MDXG) | Sale | 112,000 | $420.0K |
| Apr 12, 2022 | MIMEDX GROUP, INC. (MDXG) | Grant/Award | 602,679 | $2.78M |
| Mar 10, 2022 | MIMEDX GROUP, INC. (MDXG) | Sale | 45,611 | $221.6K |
| Feb 25, 2022 | MIMEDX GROUP, INC. (MDXG) | Sale | 61,000 | $263.1K |
| Jun 9, 2021 | MIMEDX GROUP, INC. (MDXG) | Sale | 101,957 | n/a |
| Mar 8, 2021 | MIMEDX GROUP, INC. (MDXG) | Grant/Award | 335,153 | n/a |
| Feb 22, 2021 | MIMEDX GROUP, INC. (MDXG) | Tax Withholding | 70,200 | $688.7K |
| Aug 6, 2020 | MIMEDX GROUP, INC. (MDXG) | Grant/Award | 572,033 | n/a |
| Jun 9, 2020 | MIMEDX GROUP, INC. (MDXG) | Tax Withholding | 89,591 | $313.6K |